Accelerating Clinical Trials (ACT) Alerts

One of the largest impediments to patient participation in research begins with awareness. We believed it was our goal to address this challenge and aim to increase awareness of PKD clinical studies among patients and families. The goal is to simplify the process of finding clinical studies for PKD patients in their geographic area by sending Accelerating Clinical Trials (ACT) Alert emails about studies that are being conducted.

In order to ensure that PKDF is promoting studies that address our mission to find treatments and a cure for PKD, only research approved by an ethics review board (IRB) and that meet one of the following categories will qualify for the program; there is no cost to utilize this resource.

  • Clinical trials or activities supporting clinical trial development
  • Observational studies of disease progression
  • Quality of life burden research
  • Clinical outcomes research
  • Survey tool development or validation


ACT AlertGet notified of ADPKD clinical studies in your area.


ACT AlertGet notified of ARPKD clinical studies in your area.

Schedule an ACT Alert for your study

Email for more information. 

ADPKD Registry logo

The ADPKD Registry is a collection of individuals with autosomal dominant polycystic kidney disease (ADPKD). By joining, ADPKD patients fill out questionnaires that help us identify their eligibility for clinical studies. PKDF can then provide these individuals with details on how to participate.


Page last reviewed November 2022